
Management Change30 March 2026 at 11:21 am
Asston Pharmaceuticals Appoints New CFO and Directors, Announces EGM
AI Summary
Asston Pharmaceuticals Ltd has announced the appointment of Mr. Sumit Pawar as the Chief Financial Officer, Mr. Yashvardhan Tupe as Additional Non-Executive Director, and Mr. Sandip Sharma as Additional Non-Executive Independent Director, all with effect from 30th March, 2026. The company has also approved the date and notice of the Extraordinary General Meeting scheduled on 28th April, 2026.
Key Highlights
- Asston Pharmaceuticals appoints Mr. Sumit Pawar as Chief Financial Officer
- Mr. Yashvardhan Tupe joins Asston Pharmaceuticals as Additional Non-Executive Director
- Mr. Sandip Sharma appointed as Additional Non-Executive Independent Director at Asston Pharmaceuticals
- Asston Pharmaceuticals announces Extraordinary General Meeting on 28th April, 2026
APLPharmaceuticals
Asston Pharmaceuticals LtdPrice Impact